Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Other Non Operating Income: 2021-2023

Historic Other Non Operating Income for Immuneering (IMRX) over the last 3 years, with Dec 2023 value amounting to $1.3 million.

  • Immuneering's Other Non Operating Income rose 107.97% to $464,352 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 515.32%. This contributed to the annual value of $1.3 million for FY2023, which is 515.31% up from last year.
  • According to the latest figures from FY2023, Immuneering's Other Non Operating Income is $1.3 million, which was up 515.31% from $216,844 recorded in FY2022.
  • Over the past 5 years, Immuneering's Other Non Operating Income peaked at $1.3 million during FY2023, and registered a low of -$127,063 during FY2021.
  • Moreover, its 3-year median value for Other Non Operating Income was $216,844 (2022), whereas its average is $474,683.
  • Data for Immuneering's Other Non Operating Income shows a peak YoY surged of 515.31% (in 2023) over the last 5 years.
  • Over the past 3 years, Immuneering's Other Non Operating Income (Yearly) stood at -$127,063 in 2021, then surged by 270.66% to $216,844 in 2022, then surged by 515.31% to $1.3 million in 2023.